Adaptive Biotechnologies Corp (ADPT) is trading -6% lower at $8.17 today. So far the Health Care sector has been having a mildly optimistic day, and the share price of the company is far behind it's peers.


Adaptive Biotechnologies Corp has been trading between a 52-week high of $40 and a 52-week low of $5.96. The stock has a market cap of $1.17 Billion.

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Adaptive Biotechnologies believes the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Its proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery.

Adaptive Biotechnologies Corporation (ADPT) Recovers 49.96% From Low: Are We There Yet?
Stocks Register 09-02-22

Adaptive Biotechnologies to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewswire 09-02-22

NVTA stock, ADPT stock dip as Credit Suisse issues Underperform ratings (NYSE:NVTA)
Seeking Alpha 08-25-22

Adaptive Biotechnologies Corporation (NASDAQ: ADPT): One Stock To Trade As Economic Progress Advances
Marketing Sentinel 08-23-22

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Is Down -62.47% So Far This Year: What Will Happen Next?
Stocks Register 08-22-22


As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

Such_Information_280 - -1 upvotes - source
ADPT